Edition:
United States

Insider Trading: Alere Inc (ALR_pb.N)

ALR_pb.N on New York Stock Exchange

326.17USD
2 Dec 2016
Change (% chg)

$-23.12 (-6.62%)
Prev Close
$349.29
Open
$342.76
Day's High
$342.76
Day's Low
$326.17
Volume
368
Avg. Vol
772
52-wk High
$406.88
52-wk Low
$255.75

HEMPEL PAUL T

Institutional Holders

% Shares Owned: 95.14%
# of Holders: 314
Total Shares Held: 82,776,308
3 Mo. Net Change: -796,033
# New Positions: 39
# Closed Positions: 42
# Increased Positions: 130
# Reduced Positions: 141
# Net Buyers: -11

Officers & Directors

Name Age Since Current Position

Gregg Powers

53 2014 Independent Chairman of the Board

Namal Nawana

45 2014 President, Chief Executive Officer, Director

James Hinrichs

49 2015 Chief Financial Officer, Executive Vice President

Daniella Cramp

42 2014 Global President - Cardiometabolic Business Unit

Sanjay Malkani

46 2013 Global President - Toxicology

Avi Pelossof

53 2013 Global President - Infectious Disease Business Unit

Ellen Chiniara

57 2014 Senior Vice President, General Counsel, Chief Ethics and Compliance Officer and Secretary

John Bridgen

69 2010 Senior Vice President - Business Development

Mark Gladwell

41 2015 Senior Vice President - Global Operations

Melissa Guerdan

42 2014 Senior Vice President - Global Quality and Regulatory Assurance

Robert Hargadon

59 2014 Senior Vice President - Global Human Resources

Renuka Uppaluri

45 2015 Senior Vice President - Global Research and Development

Jonathan Wygant

45 2016 Chief Accounting Officer, Vice President - Finance, Controller

Hakan Bjorklund

60 2013 Independent Director

Geoffrey Ginsburg

59 2015 Independent Director

Carol Goldberg

85 2001 Independent Director

John Levy

69 2001 Independent Director

Brian Markison

56 2013 Independent Director

Thomas McKillop

73 2013 Independent Director

John Quelch

64 2003 Independent Director

James Roosevelt

70 2009 Independent Director

Juliet Cunningham

2015 Vice President - Alere Investor Relations